|
1
|
Kang PM and Izumo S: Apoptosis in heart:
Basic mechanisms and implications in cardiovascular diseases.
Trends Mol Med. 9:177–182. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gottlieb RA, Burleson KO, Kloner RA,
Babior BM and Engler RL: Reperfusion injury induces apoptosis in
rabbit cardiomyocytes. J Clin Invest. 94:1621–1628. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olivetti G, Abbi R, Quaini F, Kajstura J,
Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski
S, et al: Apoptosis in the failing human heart. N Engl J Med.
336:1131–1141. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kearney MT, Cotton JM, Richardson PJ and
Shah AM: Viral myocarditis and dilated cardiomyopathy: Mechanisms,
manifestations, and management. Postgrad Med J. 77:4–10. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cooper LT Jr: Myocarditis. N Engl J Med.
360:1526–1538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suda T, Takahashi T, Golstein P and Nagata
S: Molecular cloning and expression of the Fas ligand, a novel
member of the tumor necrosis factor family. Cell. 75:1169–1178.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ashkenazi A and Dixit VM: Death receptors:
Signalling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krammer PH: The CD95 (APO-1/Fas) CD95L
system. Toxicol. Lett. 103:131–137. 1998.
|
|
9
|
Cheng W, Li B, Kajstura J, et al:
Stretch-induced programmed myocyte cell death. J Clin Invest.
96:2247–2259. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kajstura J, Cheng W, Reiss K, Clark WA,
Sonnenblick EH, Krajewski S, Reed JC, Olivetti G and Anversa P:
Apoptotic and necrotic myocyte cell deaths are independent
contributing variables of infarct size in rats. Lab Invest.
74:86–107. 1996.PubMed/NCBI
|
|
11
|
Yaniv G, Shilkrut M, Lotan R, Berke G,
Larisch S and Binah O: Hypoxia predisposes neonatal rat ventricular
myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1)
receptor: Fas activation and apoptosis in hypoxic myocytes.
Cardiovasc Res. 54:611–623. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Monroe EW: Desloratidine for the treatment
of chronic urticaria. Skin Therapy Lett. 7:1–5. 2002.PubMed/NCBI
|
|
13
|
Lu Y and Lu YX: Clinical application and
pharmacology function of Shenqi fuzheng injection. Shizhen Guo Yi
Guo Yao. 17:2083. 2006.(In Chinese).
|
|
14
|
Pan L: The practice of digital traditional
Chinese medicine of Shenqi Fuzheng injection. Zhongguo Chu Fang
Yao. 1:37–39. 2009.(In Chinese).
|
|
15
|
Zhong ZH: Oral history: The
industrialization of Shenqi Fuzheng injection - from proved recipe
to SFDA approved new drug. Zhongguo Chu Fang Yao. 1:33–36. 2009.(In
Chinese).
|
|
16
|
Li Y, Mai GR, Chen BF and Li T: The
relationship between the apoptosis mediated by Fas/Fasl ligand
system and virus myocarditis in mice. Shi Yong Er Ke Lin Chuang Za
Zhi. 17:631–632. 2002.(In Chinese).
|
|
17
|
Wang SH, Wang Q and Liu BC: Experience on
the treatment of viral myocarditis through the lungs. Xin Zhong Yi.
39:15–16. 2007.
|
|
18
|
Luo H, Han M and Liu JP: Systematic review
and meta-analysis of randomized controlled trials of Chinese herbal
medicine in the treatment of Sjogren's syndrome. Zhong Xi Yi Jie He
Xue Bao. 9:257–274. 2011.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiao HJ: The pharmacology efficacy and
clinical application about dangshen. Chinese Journal of Clinical
Medicine. 25:89–92. 2005.
|
|
20
|
Shao BM, Xu W, Dai H, Tu P, Li Z and Gao
XM: A study on the immune receptors for polysaccharides from the
roots of astragalus membranaceus, a Chinese medicinal herb. Biochem
Biophys Res Commun. 320:1103–1111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang MX and Cao HQ: Effects of Yi qi
compound on cardiac muscle cells of CVB3 viral myocarditis. Zhong
Guo Zhong Yi Yao Xin Xi Za Zhi She. 8:35–38. 2011.(In Chinese).
|
|
22
|
Bi MR: The association between Fas
expression and the prognosis of myocarditis. Shandong Da Xue Xue
Bao. 4:60–61. 2006.(In Chinese).
|
|
23
|
Xu CR and Zhou JH: Astragalus injection in
the treatment of acute viral myocarditis. Yi Xue Li Lun Yu Shi
Jian. 22:655–656. 2009.(In Chinese).
|
|
24
|
Cao HH and Yin HJ: Clinical practice of Yi
qi yang yin therapy on viral myocarditis. Zhong Yi Jiao Yu.
18:52–53. 1999.
|
|
25
|
Sun GY, Tong Y, Chen KW and Li QZ: Basic
theory of TCM. Beijing: Zhongguo Zhong Yi Yao Za Zhi. 8:150–153.
2002.
|
|
26
|
Zhang JH and Zhang YL: Shenqifuzheng
infusion treats viral myocarditis - observational study of 32
patients. Zhongguo Meitan Gongye Yixue Zazhi. 4:5802010.(In
Chinese).
|
|
27
|
Mei H, Ren SM and Bo L: Role of Fas/Fas
ligand apoptotic pathway of peripheral blood lymphocytes in the
development of viral myocarditis. Zhongguo Xiao Er Ji Jiu Yi Xue.
4:320–322. 2011.(In Chinese).
|
|
28
|
Niu RY, Yan XY and Wang JD: Effects of
Shenqi Fuzheng injection on the immune function in mice. Shanxi
Nong Ye Ke Xue. 36:86–88. 2008.(In Chinese).
|
